AMRN
Amarin CorpAMRN
AMRN
About: Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
Employees: 275
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
1,175% more call options, than puts
Call options by funds: $153K | Put options by funds: $12K
0% more funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]
0.43% less ownership
Funds ownership: 17.23% [Q4 2024] → 16.8% (-0.43%) [Q1 2025]
10% less capital invested
Capital invested by funds: $34.4M [Q4 2024] → $31.1M (-$3.3M) [Q1 2025]
12% less funds holding
Funds holding: 161 [Q4 2024] → 141 (-20) [Q1 2025]
26% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 38
56% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 27
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$7
47%
downside
Avg. target
$7
47%
downside
High target
$7
47%
downside
1 analyst rating
0 positive
0%
0 neutral
0%
1 negative
100%
Goldman Sachs Paul Choi | 47%downside $7 | Sell Maintained | 17 Apr 2025 |
Financial journalist opinion
Based on 3 articles about AMRN published over the past 30 days
Positive
Zacks Investment Research
4 days ago
Amarin (AMRN) Upgraded to Strong Buy: What Does It Mean for the Stock?
Amarin (AMRN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Positive
Zacks Investment Research
5 days ago
Best Momentum Stocks to Buy for June 10th
AMRN, FIX and PATH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 10, 2025.
Positive
Zacks Investment Research
5 days ago
New Strong Buy Stocks for June 10th
FIX, GHLD, AMRN, VCISY and NWFL have been added to the Zacks Rank #1 (Strong Buy) List on June 10, 2025.
Positive
Zacks Investment Research
1 month ago
Amarin's Q1 Earnings Beat Estimates, Revenues Decline Y/Y
AMRN reports better-than-expected results for the first quarter of 2025. However, the top and bottom lines decline on a year-over-year basis.
Neutral
Seeking Alpha
1 month ago
Amarin Corporation plc (AMRN) Q1 2025 Earnings Call Transcript
Amarin Corporation plc (NASDAQ:AMRN ) Q1 2025 Earnings Conference Call May 7, 2025 8:00 AM ET Company Participants Mark Marmur - Vice President of Corporate Communications and Investor Relations Aaron Berg - President and Chief Executive Officer Peter Fishman - Vice President and Global Controller Steven Ketchum - Executive Vice President, President of R&D and Chief Scientific Officer Conference Call Participants Operator Welcome to Amarin Corporation's Conference Call to discuss its First Quarter 2025 Business Update and Financial Results. I would like to turn the conference call over to Mark Marmur, Vice President, Corporate Communications and Investor Relations at Amarin.
Neutral
GlobeNewsWire
1 month ago
Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement
-- Nasdaq Compliance Follows ADS Ratio Change to Secure Company's Public Listing -- -- Amarin Remains Focused on Maximizing the Global Value of VASCEPA/VAZKEPA –
Neutral
GlobeNewsWire
1 month ago
Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025
DUBLIN and BRIDGEWATER, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin's senior management team to discuss its first quarter 2025 results followed by Q&A on Wednesday, May 7th, 2025, at 8:00 a.m. ET.
Negative
Benzinga
2 months ago
Hyatt Hotels, THOR Industries And Other Big Stocks Moving Lower On Monday
U.S. stocks were higher, with the Nasdaq Composite gaining over 200 points on Monday.
Neutral
GlobeNewsWire
2 months ago
Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change
DUBLIN and BRIDGEWATER, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today confirmed that April 11, 2025 will be the effective date for the Company's previously announced Ratio Change on its American Depositary Shares (“ADS”) -- an action in which the Company will effect a ratio change from one (1) ADS representing one (1) ordinary share to a new ratio of one (1) ADS representing twenty (20) ordinary shares (the "Ratio Change").
Neutral
GlobeNewsWire
2 months ago
Amarin Appoints JEC Capital Partners' Michael Torok to Board of Directors
DUBLIN, Ireland and BRIDGEWATER, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced the appointment of Michael Torok, Co-Founder and Managing Director of investment firm JEC Capital Partners, as a member of the Board of Directors, effective immediately.
Charts implemented using Lightweight Charts™